Researchers at Baylor College of Medicine have revealed a previously unknown mechanism by which inherited calcium channel mutations disrupt early brain development and predispose children to epilepsy and related cognitive challenges. Conclusion, published in neuronSheds new light on how subtle genetic changes can alter brain circuits long before seizures begin.
The study, conducted at the Blue Bird Circle Developmental Neurogenetic Laboratory at Baylor, focused on mutations in P/Q-type calcium channels, which are important regulators of neurotransmitter release in the brain. This mutation is thought to be associated with childhood epilepsy, but how it affects neural circuits in early development is not fully understood.
Using a mouse model to mimic childhood absence epilepsy, graduate student Samantha Thompson, and Dr. King-Long Miao, assistant professor of neurology with Baylor, were able to discover how a calcium channel mutation affects the genetic pathway.
Childhood absence epilepsy is characterized by abnormal cortical spike-wave discharges arising from the thalamocortical circuit connecting the thalamus and cortex, which controls consciousness, attention, and sensory processing.
“Although loss-of-function mutations in P/Q-type calcium channels disrupt neurotransmitter release, we were surprised to find that they also increase thalamic excitation,” Miao said.
The team found that this mutation significantly increased the expression of two downstream proepileptic genes previously associated with absence epilepsy in children. Unexpectedly, the altered calcium channels also activated a key growth-signaling pathway in the brain, known as Wnt signaling, leading to excessive proliferation of thalamic relay neurons – cells important for regulating consciousness and sensory processing.
“Surprisingly, this increase in neuronal development began before birth, indicating that the origins of the disorder lie long before the onset of seizures in childhood,” Thompson said. “The findings highlight a prenatal developmental window of vulnerability that has been largely overlooked in epilepsy research.”
The authors suggest that simultaneous regulation of two epilepsy-related gene pathways may help explain why many children fail to respond to standard single-agent antiseizure medications.
“These insights open the door to earlier diagnosis and more targeted treatments,” said Dr. Jeffrey Knoebels, director of the Blue Bird Circle Developmental Neurogenetic Laboratory. “Understanding how these pathways interact and pinpointing the right targets could change how we treat seizures and attention deficits in childhood epilepsy.”
“These findings show that inherited ion channel mutations not only affect electrical signaling – they also reshape the developmental trajectory of brain circuits,” Knoebels said.
This discovery opens new avenues for earlier detection and development of targeted therapies aimed at both neural excitation and developmental signaling pathways that may one day improve outcomes in children affected by epilepsy and related neurodevelopmental disorders.
Others participating in the research include Anika Sonnig of the Developmental Neurogenetics Laboratory at Baylor.
